282 related articles for article (PubMed ID: 9724905)
1. Formulation and in vitro evaluation of ibuprofen-Carbopol 974P-NF controlled release matrix tablets. III: Influence of co-excipients on release rate of the drug.
Khan GM; Jiabi Z
J Control Release; 1998 Jul; 54(2):185-90. PubMed ID: 9724905
[TBL] [Abstract][Full Text] [Related]
2. Studies on drug release kinetics from ibuprofen-carbomer hydrophilic matrix tablets: influence of co-excipients on release rate of the drug.
Khan GM; Zhu JB
J Control Release; 1999 Feb; 57(2):197-203. PubMed ID: 9971903
[TBL] [Abstract][Full Text] [Related]
3. Starch/Carbopol spray-dried mixtures as excipients for oral sustained drug delivery.
Pringels E; Ameye D; Vervaet C; Foreman P; Remon JP
J Control Release; 2005 Apr; 103(3):635-41. PubMed ID: 15820410
[TBL] [Abstract][Full Text] [Related]
4. [A comparative analysis of the influence of different types of Carbopol on the release rate of lithium-carbonate from matrix tablets].
Toskić-Radojcić M; Pavlović M; Gazikalović E; Arandjelović A; Kovacević A
Vojnosanit Pregl; 2012 Aug; 69(8):675-80. PubMed ID: 22924263
[TBL] [Abstract][Full Text] [Related]
5. Formulation development and investigation of ibuprofen controlled release tablets with hydrophilic polymers and the effect of co-excipients on drug release patterns.
Jan SU; Khan GM; Hussain I
Pak J Pharm Sci; 2012 Oct; 25(4):751-6. PubMed ID: 23009990
[TBL] [Abstract][Full Text] [Related]
6. Characterization and in vivo evaluation of ocular minitablets prepared with different bioadhesive Carbopol-starch components.
Weyenberg W; Bozdag S; Foreman P; Remon JP; Ludwig A
Eur J Pharm Biopharm; 2006 Feb; 62(2):202-9. PubMed ID: 16209917
[TBL] [Abstract][Full Text] [Related]
7. Ibuprofen release kinetics from controlled-release tablets granulated with aqueous polymeric dispersion of ethylcellulose II: influence of several parameters and coexcipients.
Majid Khan G; Zhu JB
J Control Release; 1998 Dec; 56(1-3):127-34. PubMed ID: 9801436
[TBL] [Abstract][Full Text] [Related]
8. An investigation into the drug release from ibuprofen matrix tablets with ethylcellulose and some poly-acrylate polymers.
Tabandeh H; Mortazavi SA
Pak J Pharm Sci; 2014 May; 27(3):495-503. PubMed ID: 24811808
[TBL] [Abstract][Full Text] [Related]
9. Incidence of drying on microstructure and drug release profiles from tablets of MCC-lactose-Carbopol and MCC-dicalcium phosphate-Carbopol pellets.
Gómez-Carracedo A; Souto C; Marti Nez-Pacheco R; Concheiro A; Gómez-Amoza JL
Eur J Pharm Biopharm; 2008 Jun; 69(2):675-85. PubMed ID: 18248805
[TBL] [Abstract][Full Text] [Related]
10. Controlled release matrix tablets of glipizide: Influence of different grades of ethocel and Co-excipient on drug release.
Mehsud SU; Khan GM; Hussain A; Akram M; Akhlaq M; Khan KA; Shakoor A
Pak J Pharm Sci; 2016 May; 29(3):779-87. PubMed ID: 27166548
[TBL] [Abstract][Full Text] [Related]
11. Role of cellulose ether polymers on ibuprofen release from matrix tablets.
Vueba ML; Batista de Carvalho LA; Veiga F; Sousa JJ; Pina ME
Drug Dev Ind Pharm; 2005 Aug; 31(7):653-65. PubMed ID: 16207613
[TBL] [Abstract][Full Text] [Related]
12. Spray-dried Amioca starch/Carbopol 974P mixtures as buccal bioadhesive carriers.
Ameye D; Mus D; Foreman P; Remon JP
Int J Pharm; 2005 Sep; 301(1-2):170-80. PubMed ID: 16019172
[TBL] [Abstract][Full Text] [Related]
13. Two release rates from monolithic carboxymethyl starch tablets: formulation, characterization, and in vitro/in vivo evaluation.
Le TC; Mateescu MA
Drug Deliv Transl Res; 2017 Aug; 7(4):516-528. PubMed ID: 28386870
[TBL] [Abstract][Full Text] [Related]
14. Drug release kinetics from tablet matrices based upon ethylcellulose ether-derivatives: a comparison between different formulations.
Khan GM; Meidan VM
Drug Dev Ind Pharm; 2007 Jun; 33(6):627-39. PubMed ID: 17613027
[TBL] [Abstract][Full Text] [Related]
15. Formulation and evaluation of controlled release matrices of ketoprofen and influence of different co-excipients on the release mechanism.
Wahab A; Khan GM; Akhlaq M; Khan NR; Hussain A; Khan MF; Khan H
Pharmazie; 2011 Sep; 66(9):677-83. PubMed ID: 22026123
[TBL] [Abstract][Full Text] [Related]
16. Development of a multi particulate extended release formulation for ZK 811 752, a weakly basic drug.
Kranz H; Le Brun V; Wagner T
Int J Pharm; 2005 Aug; 299(1-2):84-91. PubMed ID: 15970409
[TBL] [Abstract][Full Text] [Related]
17. Soluble filler as a dissolution profile modulator for slightly soluble drugs in matrix tablets.
Dvorácková K; Rabisková M; Masteiková R; Muselík J; Krejcová K
Drug Dev Ind Pharm; 2009 Aug; 35(8):930-40. PubMed ID: 19274510
[TBL] [Abstract][Full Text] [Related]
18. Effects of formulation and process variables on the release of a weakly basic drug from single unit extended release formulations.
Kranz H; Wagner T
Eur J Pharm Biopharm; 2006 Jan; 62(1):70-6. PubMed ID: 16154330
[TBL] [Abstract][Full Text] [Related]
19. Influence of excipients, drugs, and osmotic agent in the inner core on the time-controlled disintegration of compression-coated ethylcellulose tablets.
Lin SY; Lin KH; Li MJ
J Pharm Sci; 2002 Sep; 91(9):2040-6. PubMed ID: 12210050
[TBL] [Abstract][Full Text] [Related]
20. Development and evaluation of controlled release ibuprofen matrix tablets by direct compression technique.
Patel N; Madan P; Lin S
Pharm Dev Technol; 2011 Feb; 16(1):1-11. PubMed ID: 20491616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
